Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)
Mutations in the SNCA (α-synuclein, PARK1) gene significantly contribute to Parkinson’s disease and SNCA inclusions are strongly associated with PD. Fibroblasts from a 51-year-old female patient with disease onset at 39 years, carrying the A53T SNCA mutation (LCSBi003, ND40996), and fibroblasts with...
Guardado en:
Autores principales: | Gabriela Novak, Steven Finkbeiner, Gaia Skibinski, Alexander Skupin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d700714bf5cf45debcb51719cfb2ca59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learning
por: Mehrafarin Ramezani, et al.
Publicado: (2021) -
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function
por: Peter A. Barbuti, et al.
Publicado: (2021) -
A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
por: Camilla Christina Pedersen, et al.
Publicado: (2021) -
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
por: Tao Ye, et al.
Publicado: (2021) -
Microhomology-assisted scarless genome editing in human iPSCs
por: Shin-Il Kim, et al.
Publicado: (2018)